Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?

Nature Clinical Practice Cardiovascular Medicine volume 2, pages 342–343 (2005)Cite this article

boxed-textRibo M et al. (2005) Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 36: 602–606

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hacke W et al.; the ATLANTIS, ECASS, and NINDS-rt-PA Investigators (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768–774

    Article  Google Scholar 

  2. Tanne D et al. (2002) Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105: 1679–1685

    Article  CAS  Google Scholar 

  3. Warach S (2001) Tissue viability thresholds in acute stroke: the 4-factor model. Stroke 32: 2460–2461

    CAS  PubMed  Google Scholar 

  4. Davalos A et al. (2004) The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology 62: 2187–2192

    Article  CAS  Google Scholar 

  5. Chernyshev OY et al. (2005) Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke 36: 32–37

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor and Director of the Cerebrovascular Ultrasound Stroke Treatment Team at the University of Texas—Houston Medical School, TX, USA

    Andrei V Alexandrov

Authors
  1. Andrei V Alexandrov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrei V Alexandrov.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

NIH STROKE SCALE

A scale consisting of 11 items that is used to assess neurologic outcome and degree of recovery

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexandrov, A. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?. Nat Rev Cardiol 2, 342–343 (2005). https://doi.org/10.1038/ncpcardio0243

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0243

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing